Zepbound effective in obstructive sleep apnea trials - STAT - STAT

Eli Lilly reported Wednesday that the GLP-1 drug cut breathing interruptions in obese or overweight patients experiencing the condition.

By: STAT

Apr 19 2024
0
0 Views

Eli Lilly reported positive results for its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market. The results also pave the way… [+680 chars]

Google announces more layoffs, plans to relocate jobs overseas - San Francisco Chronicle

Micron Poised to Get Over $6 Billion in Chips Grants in Announcement Next Week - Bloomberg

No landing, no Fed rate cuts: the markets' new bet on 2024 - TheStreet

Latest Oil Prices, Market News and Analysis for April 18 - Bloomberg

Stock futures are little changed after S&P 500 posts a fourth losing day: Live updates - CNBC

FTC may try to block yet another business merger - Fox Business

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network